First synthesis of racemic saphenamycin and its enantiomers. Investigation of biological activity

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 5, 2003, Pages 723-731

  Laursen, Jane B ^a   Jørgensen, Charlotte G ^a   Nielsen, John ^a,b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

6 [1 (2 HYDROXY 6 METHYL BENZOYLOXY) ETHYL] PHENAZINE 1 CARBOXYLIC ACID; ANTIBIOTIC AGENT; BRUCINE; SAPHENAMYCIN; SAPHENIC ACID; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CRYSTALLIZATION; DRUG ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RACEMIC MIXTURE; SCREENING; SKIN FLORA; STAPHYLOCOCCUS AUREUS; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANTI-BACTERIAL AGENTS; BACTERIA; CHEMISTRY, PHYSICAL; CRYSTALLOGRAPHY, X-RAY; INDICATORS AND REAGENTS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PHENAZINES; SALICYLIC ACIDS; STEREOISOMERISM;

STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0037354832     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00472-8     Document Type: Article

References (25)

1. Hélène C. Nature. 391:1998;436.
2. Cao, Y. and He, X.-W. Spectrochim. Acta, Part A 1998, 54, 883.
3. Berman H.M., Young P.R. Ann. Rev. Biophys. Bioeng. 10:1981;87.
4. Neidle, S.; Laughton, C. A. In The Search for New Anticancer Drugs; Waring, M. J., Ponder, B. A. J., Eds.; Kluwer Academic: Lancaster, UK, 1992; p 133.
5. Michel, K. H.; Hoehn, M. M. US Patent 4,316,959, 1982; Chem. Abstr., 1982, 96, 197888.
6. Michel, K. H.; Hoehn, M. M. US Patent 4,316,959, 1982; Chem. Abstr., 1982, 96, 197888.
7. Kitahara M., Nakamura H., Matsuda Y., Hamada M., Naganawa H., Maeda K., Umezawa H., Itaka Y. J. Antibiot. 1982;1412.
8. Keller-Schierlein W., Geiger A., Zähner H., Brandl M. Helv. Chim. Acta. 71:1988;2058.
9. Geiger A., Keller-Schierlein W., Brandl M., Zähner H. J. Antibiot. 41:1988;1542.
10. Kerr J.R. Infect. Dis. Rev. 2:2000;184.
11. Laursen J.B., de Visser P., Nielsen H.K., Jensen K.J., Nielsen J. Bioorg. Med. Chem. Lett. 12:2002;171.
12. Hollstein U., Van Gemert R. Jr. J. Biochem. 10:1971;497.
13. Mosher C.W., Lee D.-Y., Enanoza R.M., Sturm P.A., Kuhlmann K.F. J. Med. Chem. 22:1979;918.
14. Hauser F.M., Pogany S.A. Synthesis. 1980;814.
15. Petersen L., Jensen K.J., Nielsen J. Synthesis. 10:1999;1763.
16. Bahnmüller U., Keller-Schierlein W., Brandl M., Zähner H., Diddens H. J. Antibiot. 41:1988;1552.
17. Wissner A., Grudzinskas C.V. J. Org. Chem. 43:1978;3972.
18. Greene T.W., Wuts P.G.M. Protective Groups in Organic Synthesis. 3rd ed. 1999;John Wiley & Sons, New York.
19. Alsina J., Rabanal F., Chiva C., Giralt E., Albericio F. Tetrahedron. 54:1998;10125.
20. All other NMR data were similar to the corresponding acid. For related example, see: Islam, R., Joule, J. A. J. Chem. Res. (M) 1990, 364.
21. Van't Land C.W., Mocek U., Floss H.G. J. Org. Chem. 58:1993;6576.
22. Yun B.-S., Ryoo I.-J., Kim W.-G., Kim J.-P., Koshino H., Seto H., Yoo I.-D. Tetrahedron Lett. 37:1996;8529.
23. Ezquerra J., Yyruretagoyena B., Avendano C., de la Cuesta E., González R., Prieto L., Pedregal C., Espada M., Prowse W. Tetrahedron. 51:1995;3271.
24. Tichý M., Zàvada J., Podlaha J., Vojtísek P. Tetrahedron: Asymmetry. 6:1995;1279.
25. Crystallographic data (excluding structure factors) for the structure in this paper has been deposited with the Cambridge Crystallographic Data Centre as supplementary publication nos. CCDC 187894. Copies of the data can be obtained, free of charge, on application via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the CCDC, 12 Union Road, Cambridge CB2 1EZ, UK, fax: +44-1223-336033, e-mail: deposit@ccdc.cam.ac.uk).